This article was originally published in The Tan Sheet
Enzyte marketer Berkeley Premium Nutraceuticals "has been able to reduce customer complaints by 90% and has held a steady average of less than two per week" during the past 24 months, the firm announces Sept. 6. The company has spent "well over $20 mil." to buy equipment and create the necessary departments to ensure total industry compliance, and has confirmed through four separate third-party surveys that customers are very satisfied with Berkeley brands. The firm recently paid $2.5 mil. in settlement and restitution costs in a consent agreement that arose from thousands of consumer complaints in six states (1"The Tan Sheet" March 6, 2006, p. 8)...
You may also be interested in...
Berkeley Premium Nutraceuticals will pay $2.5 mil. in legal costs and restitution in accordance with a consent agreement, the firm announced March 1
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.